Retatrutide

Retatrutide – a cutting-edge, high-quality peptide at the forefront of obesity and metabolic disorder research. Designed as a triple receptor agonist, Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, producing a synergistic effect on metabolic regulation, appetite suppression, insulin activity, and fat utilization.